Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 6433  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
   Navigate here  
     Search
     Current Issue
     Submit Article 
     My Preferences 

Follow us on:

Twitter Icon Linkedin Icon Instagram Icon Facebook Icon

 


This article has been cited by
1Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis
Alireza Hedayatfar,Khalil Ghasemi Falavarjani,Masoud Soheilian,Navid Elmi Sadr,Mehdi Modarres,Mohammad Mehdi Parvaresh,Masood Naseripour,Mohammad Rohani,Mostafa Almasi,Soon-Phaik Chee
Ocular Immunology and Inflammation.2017;25(3)308
[DOI]
2Mycophenolate mofetil in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations
Margherita Nosadini,Jonathan Gadian,Ming Lim,Stefano Sartori,Terrence Thomas,Russell C Dale
Developmental Medicine & Child Neurology.2019;61(4)458
[DOI]
3Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients
Rami Fakih,Marcelo Matiello,Tanuja Chitnis,James M. Stankiewicz
Journal of Neurology.2018;265(11)2688
[DOI]
Online since 20th March '04
Published by Wolters Kluwer - Medknow